Economic Impact of Obesity

Goldman Sachs predicts AI could boost GDP by 1.2% annually, but the staggering $1.7 trillion cost of obesity in the U.S. presents an even greater opportunity for economic improvement. Nova Nordisk, the company behind popular weight-loss drugs, has skyrocketed in value, highlighting the potential of addressing obesity. With 73% of Americans classified as overweight or obese, the implications for both health and the economy are profound, potentially surpassing the benefits of AI advancements.